BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36563921)

  • 21. Cannabinoid use is enhanced by stress and changes conditioned stress responses.
    Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C
    Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study.
    Pelgrim TAD; Ramaekers JG; Wall MB; Freeman TP; Bossong MG
    Drug Alcohol Depend; 2023 Oct; 251():110925. PubMed ID: 37598453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
    Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB
    Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
    Kayser RR; Haney M; Raskin M; Arout C; Simpson HB
    Depress Anxiety; 2020 Aug; 37(8):801-811. PubMed ID: 32383271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational models of cannabinoid vapor exposure in laboratory animals.
    Moore CF; Stiltner JW; Davis CM; Weerts EM
    Behav Pharmacol; 2022 Apr; 33(2&3):63-89. PubMed ID: 33136615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states.
    Zaytseva Y; Horáček J; Hlinka J; Fajnerová I; Androvičová R; Tintěra J; Salvi V; Balíková M; Hložek T; Španiel F; Páleníček T
    J Psychopharmacol; 2019 Jul; 33(7):811-821. PubMed ID: 31154891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Eur Neuropsychopharmacol; 2021 Oct; 51():106-131. PubMed ID: 34273801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use.
    Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L
    Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoids, reward processing, and psychosis.
    Gunasekera B; Diederen K; Bhattacharyya S
    Psychopharmacology (Berl); 2022 May; 239(5):1157-1177. PubMed ID: 33644820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents.
    Skumlien M; Freeman TP; Hall D; Mokrysz C; Wall MB; Ofori S; Petrilli K; Trinci K; Borissova A; Fernandez-Vinson N; Langley C; Sahakian BJ; Curran HV; Lawn W
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Feb; 8(2):219-229. PubMed ID: 36642667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Medical Cannabinoids Dosing in Human.
    Campos DA; Mendivil EJ; Romano M; García M; Martínez ME
    Clin Ther; 2022 Dec; 44(12):e39-e58. PubMed ID: 36411116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.
    Hindley G; Beck K; Borgan F; Ginestet CE; McCutcheon R; Kleinloog D; Ganesh S; Radhakrishnan R; D'Souza DC; Howes OD
    Lancet Psychiatry; 2020 Apr; 7(4):344-353. PubMed ID: 32197092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.